Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma

scientific article published on 01 June 2000

Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1034/J.1600-0676.2000.020003209.X
P698PubMed publication ID10902970

P2093author name stringT Ohta
K Endo
T Ueda
T Terada
P433issue3
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)209-215
P577publication date2000-06-01
P1433published inLiverQ27711906
P1476titleProtein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma
P478volume20

Reverse relations

cites work (P2860)
Q36092123Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis
Q37445665Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population
Q40030453Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma
Q33739952Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma
Q30832108Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators
Q35942016Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysis
Q24296626DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control
Q24336795E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein
Q34360157Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice
Q35011207Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma
Q46761401MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis
Q39205410MDM2 is a useful prognostic biomarker for resectable gastric cancer
Q52340395MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
Q30165307Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma
Q78357688Molecular pathogenesis of human hepatocellular carcinoma
Q38280688Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis
Q37225447Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/twist1 pathway
Q43137700RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.
Q33825600Response of the hepatic transcriptome to aflatoxin B1 in domestic turkey (Meleagris gallopavo).
Q37809251Signaling Networks in Human Hepatocarcinogenesis—Novel Aspects and Therapeutic Options
Q40262791TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.
Q46151710TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis
Q34668320The prognostic molecular markers in hepatocellular carcinoma

Search more.